Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

Which statement accurately describes menstrual-related migraine management?

Menstrual-related migraine is best managed with a combination approach that addresses both the immediate attacks and the underlying cycle-related risk. For acute relief around menses, NSAIDs and triptans are commonly used to abort or lessen an attack when it begins. In addition, preventive options are considered to reduce the number of episodes across the menstrual cycle, including CGRP monoclonal antibodies and hormonal strategies (such as continuous estrogen-containing contraception or other hormonal regimens) to stabilize hormonal fluctuations. Some patients also use short-acting triptans as short-term prophylaxis during the perimenstrual period. This multifaceted plan—treating attacks as they occur and implementing preventive strategies to blunt recurrence—best reflects current practice. Relying on only NSAIDs, or only hormonal approaches, or withholding pharmacologic therapy altogether, misses important aspects of effective menstrual-related migraine management.

Menstrual-related migraine is best managed with a combination approach that addresses both the immediate attacks and the underlying cycle-related risk. For acute relief around menses, NSAIDs and triptans are commonly used to abort or lessen an attack when it begins. In addition, preventive options are considered to reduce the number of episodes across the menstrual cycle, including CGRP monoclonal antibodies and hormonal strategies (such as continuous estrogen-containing contraception or other hormonal regimens) to stabilize hormonal fluctuations. Some patients also use short-acting triptans as short-term prophylaxis during the perimenstrual period. This multifaceted plan—treating attacks as they occur and implementing preventive strategies to blunt recurrence—best reflects current practice. Relying on only NSAIDs, or only hormonal approaches, or withholding pharmacologic therapy altogether, misses important aspects of effective menstrual-related migraine management.